Topic: Reproducibility Crisis

The Economist reports on the "reproducibility crisis" in modern science, noting that many seminal studies cannot be replicated. Researchers at Bayer Healthcare successfully reproduced only 25% of 67 major studies in drug discovery. The hosts argue that the lack of motivation for reproducible studies undermines the credibility of the scientific community.

The medical journal The Lancet has highlighted a crisis in scientific research, noting that a significant portion of published studies are unreproducible due to data manipulation and a broken peer review process. The hosts discuss how these issues are being debated under "Chatham House Rules," which allow for the use of information while protecting the identity of the speakers.